Discovery of Cobimetinib as a novel A-FABP inhibitor using machine learning and molecular docking-based virtual screening

Shilun Yang(Chinese Academy of Sciences), Junlei Chang(Chinese Academy of Sciences)
RSC Advances
January 1, 2022
Cited by 20


Related Papers